Posted on | February 25, 2011 | Comments Off
The Board of Regents approved the bachelor of arts in pharmacy studies and the doctorate in pharmaceutical sciences as provisional programs at Hilo’s College of Pharmacy effective fall 2011. The College of Pharmacy currently offers a curriculum leading to the doctor of pharmacy with the first class of student pharmacists scheduled to graduate in May 2011.
The BAPS degree is designed for students enrolled in the PharmD program in the College of Pharmacy. Students who enter the PharmD program at Hilo are required to have met pre-pharmacy requirements, but they are not required to have earned a bachelor’s degree. The PharmD curriculum is rigorous and requires four years of studies, surpassing the requirements of a bachelor’s level degree. By providing the BAPS degree option, students will have the opportunity to have their academic achievements properly recognized.
The doctorate in pharmaceutical sciences will be the first program of this type to be offered by the University of Hawaiʻi, and the only program of this nature to be offered in the state of Hawaiʻi and the Pacific region. It will significantly elevate the culture of research, development and technology transfer in the pharmaceutical sciences, with an emphasis on natural products discovery and development and their importance in pharmacy and healthcare in general.
“Each of these programs expands our ability to offer students more options in a changing world landscape,” says College of Pharmacy Dean John M. Pezzuto. “The BAPS degree will enhance educational opportunities for our PharmD students and make them more competitive in the marketplace. The doctorate in pharmaceutical sciences complements the PharmD program by exposing students to career prospects beyond the practice of pharmacy. We’ve been building these degree options since the founding of the college.”